The present invention relates to recombinant
batroxobin and a method for its preparation on an
industrial scale with high expression level. Specifically, the method for preparing recombinant
batroxobin according to the present invention is to artificially synthesize the
structural gene sequence of
batroxobin, then use
Pichia pastoris to clone and express to screen and obtain the seed liquid of a high-expression
engineering strain, and then ferment and culture to prepare recombinant batroxobin according to the following operations: preparation of primary seed liquid, preparation of secondary seed liquid,
inoculation and pre-culture in a fermenter,
glycerol fed-batch culture,
methanol fed-batch induction culture, concentration to obtain a
fermentation concentrate containing recombinant batroxobin and optionally purifying it. This recombinant batroxobin can be clinically used for
acute cerebral infarction, for improving ischemic symptoms caused by various occlusive vascular diseases (such as thromboangiitis obliterans, deep phlebitis,
pulmonary embolism, etc.), and for improving
peripheral and
microcirculation disorders (such as sudden deafness,
motion sickness). The expression level of batroxobin by the method of the present invention is high, and industrial-scale production can be easily achieved.